Autophagy inhibition enhances pan-Bcl-2 inhibitor AT-101-induced apoptosis in non-small cell lung cancer

Neoplasma

Volumn 61, Issue 2, 2014, Pages 186-192

  Mei, H ^a   Lin, Z ^a   Wang, Y ^a   Wu, G ^a   Song, Y ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Autophagy; BH3; Lung cancer

Indexed keywords

ISOSORBIDE; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG NON SMALL CELL CANCER; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS, AUTOPHAGY, BH3, LUNG CANCER;

APOPTOSIS; AUTOPHAGY; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GOSSYPOL; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84893162249     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_024     Document Type: Article

References (31)

1. SPIRO SG, TANNER NT, SILVESTRI GA, JANES SM, LIM E et al. Lung cancer: progress in diagnosis, staging and therapy. Respirology 2010; 15: 44-50. http://dx.doi.org/10.1111/j.1440-1843.2009.01674.x
2. CORY S, ADAMS JM The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2: 647-656. http://dx.doi.org/10.1038/nrc883
3. KANG M, Reynolds CP Bcl-2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009; 15: 1126-1132. http://dx.doi.org/10.1158/1078-0432.CCR-08-0144
4. DANIAL NN BCL-2 family proteins: Critical checkpoints of apoptotic cell death. Clin Cancer Res 2007; 13: 7254-7263. http://dx.doi.org/10.1158/1078-0432.CCR-07-1598
5. WESARG E, HOFFARTH S, WIEWRODT R, KROLL M, BIESTERFELD S et al. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer. Int J Cancer 2007; 121: 2387-2394. http://dx.doi.org/10.1002/ijc.22977
6. ZHANG H, GUTTIKONDA S, ROBERTS L, UZIEL T, SEMIZAROV D et al. Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines. Oncogene 2011; 30: 1963-1968. http://dx.doi.org/10.1038/onc.2010.559
7. WOLTER KG, WANG SJ, HENSON BS, WANG S, GRIFFITH KA et al. (-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo. Neoplasia 2006; 8: 163-172. http://dx.doi.org/10.1593/neo.05691
8. KLINE MP, RAJKUMAR SV, TIMM MM, KIMLINGER TK, HAUG JL et al. R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells. Exp Hematol 2008; 36: 568-576. http://dx.doi.org/10.1016/j.exphem.2008.01.003
9. BALAKRISHNAN K, WIERDA WG, KEATING MJ, GANDHI V GOSSYPOL, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells. Blood 2008; 112: 1971-1980. http://dx.doi.org/10.1182/blood-2007-12-126946
10. CHEONG H, LU C, LINDSTEN T, THOMPSON CB Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol 2012; 30: 671-678. http://dx.doi.org/10.1038/nbt.2285
11. MEILER J, SCHULER M Therapeutic targeting of apoptotic pathways in cancer. Curr Drug Targets 2006; 7: 1361-1369. http://dx.doi.org/10.2174/138945006778559175
12. PATTINGRE S, LEVINE B Bcl-2 inhibition of autophagy: a new route to cancer? Cancer Res 2006; 66: 2885-2888. http://dx.doi.org/10.1158/0008-5472.CAN-05-4412
13. LUO S, RUBINSZTEIN DC Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ 2007; 14: 1247-1250. http://dx.doi.org/10.1038/sj.cdd.4402149
14. BARAKAT K, GAJEWSKI M, TUSZYNSKI JA DNA repair inhibitors: the next major step to improve cancer therapy. Curr Top Med Chem 2012; 12: 1376-1390. http://dx.doi.org/10.2174/156802612801319070
15. WARR MR, SHORE GC Small-molecule Bcl-2 antagonists as targeted therapy in oncology. Curr Oncol 2008; 15: 256-261. http://dx.doi.org/10.3747/co.v15i6.392
16. GAO P, BAUVY C, SOUQUERE S, TONELLI G, LIU L et al. The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells. J Biol Chem 2010; 285: 25570-25581. http://dx.doi.org/10.1074/jbc.M110.118125
17. MEHRPOUR M, ESCLATINE A, BEAU I, CODOGNO P Autophagy in health and disease. 1. Regulation and significance of autophagy: an overview. Am J Physiol Cell Physiol 2010; 298: 776-785. http://dx.doi.org/10.1152/ajpcell.00507.2009
18. KREUZALER P, WATSON CJ Killing a cancer: what are the alternatives? Nat Rev Cancer 2012; 12: 411-424. http://dx.doi.org/10.1038/nrc3264
19. COTTER TG Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009; 9: 501-507. http://dx.doi.org/10.1038/nrc2663
20. KROEMER G, GALLUZZI L, BRENNER C Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99-163. http://dx.doi.org/10.1152/physrev.00013.2006
21. WILLIS SN, FLETCHER JI, KAUFMANN T, VAN DELFT MF, CHEN L et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not bax or bak. Science 2007; 315: 856-859. http://dx.doi.org/10.1126/science.1133289
22. CHEN L, WILLIS SN, WEI A, SMITH BJ, FLETCHER JI et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393-403. http://dx.doi.org/10.1016/j.molcel.2004.12.030
23. STRASSER A, HARRIS AW, JACKS T, CORY S DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by bcl-2. Cell 1994; 79: 329-339. http://dx.doi.org/10.1016/0092-8674(94)90201-1
24. SCHMITT CA, ROSENTHAL CT, LOWE SW Genetic analysis of chemoresistance in primary murine lymphomas. Nat Med 2000; 6: 1029-1035. http://dx.doi.org/10.1038/79542
25. KAUFMANN SH, VAUX DL Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 2003; 22: 7414-7430. http://dx.doi.org/10.1038/sj.onc.1206945
26. ZANGEMEISTER-WITTKE U, LEECH SH, OLIE RA, SIMOES-WUST AP, GAUTSCHI O et al. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells. Clin Cancer Res 2000; 6: 2547-2555.
27. RUDIN CM, KOZLOFF M, HOFFMAN PC, EDELMAN MJ, KARNAUSKAS R et al. Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer. J Clin Oncol 2004; 22: 1110-1117. http://dx.doi.org/10.1200/JCO.2004.10.148
28. KLASA RJ, GILLUM AM, KLEM RE, FRANKEL SR Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment. Antisense Nucleic Acid Drug Dev 2002; 12: 193-213. http://dx.doi.org/10.1089/108729002760220798
29. READY N, KARASEVA NA, ORLOV SV, LUFT AV, POPOVYCH O et al. Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer. J Clin Oncol 2011; 6: 781-785]
30. HUANG S, SINICROPE FA Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells. Autophagy 2010; 6: 256-269. http://dx.doi.org/10.4161/auto.6.2.11124
31. SALEEM A, DVORZHINSKI D, SANTANAM U, MATHEW R, BRAY K et al. Effect of dual inhibition of apoptosis and autophagy in prostate cancer. Prostate 2012; 72: 1374-1381. http://dx.doi.org/10.1002/pros.22487